Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05629585 |
|---|---|
| Brief Title: | A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) |
| First Submitted : | November 4, 2022 |
| First Submitted that Met QC Criteria : | November 17, 2022 |
| First Posted : | November 29, 2022 |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 8, 2024 |